Barry James sold 1,400 shares of BIO-RAD LABORATORIES, INC. on Nov 9, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
EVP, President, LSG
EVP, President, LSG
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
1,400Bio-Rad A Common Stock
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
69.15%This security and ownership context
Holdings after
624.682Direct
Trade date
Nov 9, 2026Sell
Filed
Nov 12, 2026, 10:56 AM ET3-day reporting delay
Accession
0000012208-26-000060Code S · Transaction 398413
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 2,024.682 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

BIO BIO.B price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BIO BIO.B · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $385.588 to $385.645, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.